Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Moca scores sits at the center of this dementia and brain health question.
MoCA scores can reveal patterns that suggest vascular dementia, but the relationship is more complex than with other dementia types. When someone scores between 22 and 25 on the Montreal Cognitive Assessment, it may indicate vascular cognitive impairment, which often precedes vascular dementia. However, the MoCA’s ability to specifically identify vascular dementia from other dementia types is limited—research shows an accuracy (AUC) of only 0.583 when distinguishing vascular dementia from Alzheimer’s disease or other neurodegenerative conditions. This means the test can flag that cognitive problems exist, but it struggles to pinpoint whether those problems come from vascular causes rather than other origins. Consider a 68-year-old man with a history of high blood pressure and a previous stroke who scores 23 on the MoCA. His score falls in the range that suggests mild cognitive impairment, and his stroke history points toward vascular causes.
Yet this same score could also appear in someone with early Alzheimer’s disease. Without additional imaging, blood pressure history, and stroke documentation, the MoCA score alone cannot confidently distinguish between these possibilities. This is the core pattern that emerges from vascular dementia research: the test identifies cognitive decline, but its specificity for vascular origins is weak. Understanding what MoCA scores mean in the context of vascular dementia requires knowing both what the numbers represent and what they don’t tell us. The score provides a starting point for further investigation, not a definitive diagnosis. For patients and caregivers, this means that a concerning MoCA result warrants additional clinical evaluation, imaging studies, and assessment of vascular risk factors.
Table of Contents
- How MoCA Scoring Reveals Cognitive Decline in Vascular Conditions
- Why MoCA Has Limited Ability to Distinguish Vascular Dementia from Other Types
- Clinical Detection Patterns in Stroke and TIA Patients
- Baseline Scores and Progression Patterns in Small Vessel Disease
- The MoCA as Screening Tool, Not Diagnostic Instrument
- Comparing MoCA Results Across Dementia Types
- Emerging Research and Clinical Implications for the Future
- Conclusion
How MoCA Scoring Reveals Cognitive Decline in Vascular Conditions
The moca uses a 30-point scale with different thresholds than standard dementia screening tests. A score of 26 or higher is generally considered normal, but for vascular cognitive impairment specifically, a score of 22 becomes the critical cutoff. This lower threshold—22 instead of 26—exists because vascular damage to the brain tends to affect cognition differently than Alzheimer’s pathology. Researchers identified 22 as the optimal cutoff for detecting vascular cognitive impairment based on studies of large populations, including Chinese normative data that established how vascular disease affects MoCA performance. Scores between 22 and 25 suggest mild cognitive impairment that may relate to vascular causes, particularly in patients with stroke history or cerebrovascular disease.
Scores between 18 and 21 indicate mild-to-moderate cognitive impairment, where functional difficulties become more apparent in daily life. A score below 18 reflects moderate-to-severe cognitive decline. For comparison, people without cognitive impairment average 27.4 on the MoCA, while those with vascular cognitive impairment often cluster around the 22-25 range, and patients with established vascular dementia may score even lower depending on disease severity. The pattern that emerges is that vascular damage often produces more scattered cognitive deficits than Alzheimer’s disease, because strokes and small vessel disease affect specific brain regions depending on where the vascular damage occurs. A person with a stroke in the left frontal lobe may have different MoCA patterns than someone with widespread small vessel disease affecting white matter throughout the brain. This variability means that the same score may represent different underlying problems in different patients.
Why MoCA Has Limited Ability to Distinguish Vascular Dementia from Other Types
MoCA’s weakness in differentiating vascular dementia from other dementia types represents a significant clinical limitation. A 2024-2025 research analysis found that when comparing vascular dementia to Alzheimer’s disease, frontotemporal dementia, and dementia with Lewy bodies, the MoCA achieved only moderate accuracy in distinguishing between them. The Area Under the Curve (AUC) of 0.583 for vascular dementia specifically means the test performs only slightly better than a coin flip at separating vascular dementia from other types—well below the 0.7 or higher threshold considered clinically useful for diagnostic differentiation. This limitation matters because treatment, prognosis, and management strategies differ between vascular dementia and other dementia types. Vascular dementia often responds to blood pressure management, anticoagulation, and stroke prevention in ways that Alzheimer’s disease does not.
Yet the MoCA alone cannot reliably tell a patient or clinician which disease is actually present. Someone scoring 20 on the MoCA might have vascular dementia, Alzheimer’s disease, or a combination of both (mixed dementia). The moca score indicates severity of cognitive decline but provides little guidance about its cause. This is why the National Institutes of Health and Canadian Stroke Network recommend using only selected subsets of the MoCA for vascular cognitive impairment detection, not the full 30-item test. Clinicians working with post-stroke patients or those with known cerebrovascular disease often rely more heavily on brain imaging (MRI or CT showing infarcts or small vessel disease), blood pressure history, and vascular risk factor profiles than on MoCA scores alone to establish whether cognitive decline is genuinely vascular in origin. The warning here is clear: a MoCA result should never be interpreted as a vascular dementia diagnosis without supporting evidence from imaging and medical history.
Clinical Detection Patterns in Stroke and TIA Patients
The MoCA reveals cognitive impairment in stroke and transient ischemic attack (TIA) patients at surprisingly high rates. Research found that the MoCA detected cognitive impairment in approximately 65% of subjects three months after a stroke, even when those same patients scored normal on the MMSE (Mini-Mental State Examination), a simpler and older screening tool. This means the MoCA is more sensitive to subtle cognitive changes following stroke than other tests, which is both a strength and a source of potential confusion. Among patients with TIA or stroke history, between 30% and 58% scored below normal on the MoCA despite scoring normal on the MMSE. This gap suggests that the MoCA catches cognitive problems—particularly in attention, executive function, and processing speed—that the MMSE misses. In a real-world example, a 72-year-old woman who suffered a TIA without major visible infarction might score 28 on the MMSE (normal) but 24 on the MoCA (suggesting mild cognitive impairment).
Her MoCA score reflects genuine cognitive slowing and word-finding difficulties that affect her daily functioning, even though the older test said she was fine. This higher sensitivity of the MoCA makes it valuable for identifying patients at risk for progression to vascular dementia. However, this same sensitivity creates a challenge: the MoCA may detect subclinical cognitive changes that don’t yet represent true cognitive impairment requiring treatment. Not every patient with a MoCA score of 24 or 25 will progress to dementia. Some may remain stable for years, while others may improve slightly as the brain compensates after stroke. The clinical context—whether the patient is experiencing functional decline, what their baseline cognition was before the stroke, and whether imaging shows progressive small vessel disease—determines whether the MoCA finding represents true vascular cognitive impairment or temporary post-stroke effects.
Baseline Scores and Progression Patterns in Small Vessel Disease
Small vessel disease represents a common vascular pathway to dementia, and MoCA scores track progression patterns in these patients. Research from the VMCI-Tuscany Study and other longitudinal investigations found that baseline MoCA scores predicted outcomes in small vessel disease. Patients with small vessel disease plus mild cognitive impairment who progressed to major neurocognitive disorder had baseline MoCA scores averaging 20.5 ± 5, while those whose cognitive impairment remained stable or improved had higher baseline scores of 22.2 ± 4.3. This pattern—lower baseline scores predicting worse outcomes—follows an intuitive trajectory but also carries important nuance. A baseline score of 20 does not guarantee progression to dementia, nor does a score of 22 guarantee stability. Other factors influence progression, including the volume and distribution of white matter lesions on brain MRI, blood pressure control, presence of diabetes, and adherence to medications.
Yet the MoCA score provides a useful anchor point for tracking change over time. If a patient scores 23 initially and scores 20 a year later, that three-point decline signals meaningful cognitive change requiring reassessment and potential treatment adjustments. Comparing this to Alzheimer’s disease, where typical MoCA scores in established disease average 16.2, small vessel disease patients often retain higher function longer. The vascular pattern tends to involve pockets of damage rather than the more diffuse pathology of Alzheimer’s, meaning some cognitive domains remain relatively preserved while others decline. A patient with small vessel disease might score low on executive function and processing speed items but relatively well on memory items, whereas Alzheimer’s disease typically impairs memory early and broadly. These patterns provide subtle clues about underlying disease type, though they should not replace neuroimaging in clinical decision-making.
The MoCA as Screening Tool, Not Diagnostic Instrument
One of the most important limitations of MoCA—and one frequently misunderstood by patients and some clinicians—is that it is a screening tool, not a diagnostic instrument. A low MoCA score indicates that cognitive impairment may be present and warrants further investigation. It does not diagnose any specific condition, including vascular dementia. This distinction matters profoundly because screening identifies possible problems, while diagnosis confirms them through multiple lines of evidence. A warning for patients and caregivers: a single low MoCA score should never be interpreted as a definitive dementia diagnosis.
If someone scores 19 on the MoCA, that result says, “Cognitive impairment is likely present; more testing is needed,” not “You have dementia.” The next steps must include detailed neuropsychological testing to assess specific cognitive domains, brain imaging to identify structural changes or infarcts, blood work to rule out metabolic causes like thyroid disease or B12 deficiency, and detailed medical history assessment. Only after this comprehensive evaluation can a clinician confidently diagnose vascular dementia or rule it out. Additionally, MoCA performance can be affected by depression, anxiety, medication side effects, sleep deprivation, and low education level, none of which indicate dementia. A highly educated person scoring 21 on the MoCA might represent genuine cognitive decline, while someone with less formal education scoring the same might actually be performing at their baseline. Accurate interpretation requires knowledge of the patient’s educational background, current mood, medication list, and prior cognitive abilities. The MoCA provides data, but clinical judgment contextualized with other information determines its meaning.
Comparing MoCA Results Across Dementia Types
Understanding vascular dementia MoCA patterns becomes easier when compared directly to other dementia types. People without cognitive impairment average 27.4 on the MoCA, representing normal aging. Those with mild cognitive impairment (regardless of cause) average 22.1, placing them at or near the vascular dementia detection threshold. However, people with Alzheimer’s disease at the dementia stage average 16.2, reflecting more severe global cognitive decline. This downward progression shows how MoCA captures increasing severity, but it obscures the underlying differences in disease mechanisms.
The practical comparison for vascular dementia patients: if someone scores 21 on the MoCA, knowing that Alzheimer’s patients average 16 doesn’t clarify whether this person has vascular dementia, Alzheimer’s, or both (mixed dementia). What it does show is that cognitive impairment is present and of mild-to-moderate severity. For patients with known stroke history or documented small vessel disease, that 21 suggests vascular involvement is likely. For someone without vascular risk factors or imaging evidence, other causes become more probable. The score’s meaning shifts based on context, which is why MoCA is most useful within a comprehensive clinical assessment rather than as a standalone result.
Emerging Research and Clinical Implications for the Future
Research continues to refine how clinicians should interpret MoCA scores in vascular dementia contexts. The recognition that a score of 22 serves as the optimal cutoff specifically for vascular cognitive impairment, distinct from the standard 26-point normal threshold, represents relatively recent progress. As more longitudinal studies track MoCA changes in stroke survivors and small vessel disease patients over years, clinicians gain better understanding of which score patterns predict progression versus stability.
The future likely involves combining MoCA scores with biomarkers and advanced imaging to improve diagnostic accuracy. Fluid biomarkers that detect vascular damage, white matter lesion volumes on MRI, and perhaps genetic markers for cerebrovascular disease risk may eventually allow clinicians to use MoCA scores within a composite picture rather than relying on cognitive testing alone. For patients undergoing MoCA screening today, this means that while the test has limitations, it remains a valuable starting point that should prompt appropriate follow-up investigations rather than definitive conclusions.
Conclusion
MoCA scores in vascular dementia reveal patterns of cognitive decline but do not specifically diagnose vascular disease as the cause. A score between 22 and 25 suggests mild cognitive impairment that may relate to vascular damage, particularly in patients with stroke history or known cerebrovascular disease. Scores progressively lower indicate greater cognitive impairment, with a score below 18 reflecting moderate-to-severe decline. The pattern emerges through comparison to typical scores in other conditions and through attention to vascular risk factors in the patient’s history.
The most important takeaway is that MoCA results should launch further investigation, not conclude it. If you or a loved one receives a concerning MoCA score, the next steps are comprehensive neuropsychological testing, brain imaging to assess for strokes or small vessel disease, blood work to rule out treatable causes, and detailed medical evaluation of vascular risk factors. A neurologist or cognitive specialist can interpret the MoCA result within this broader context and guide appropriate next steps toward accurate diagnosis and management. The test provides valuable information about cognitive function, but diagnosis of vascular dementia requires multiple converging pieces of evidence.
You Might Also Like
- MoCA Language Tasks and Dementia: What Families Notice
- How Fast Do MoCA Scores Decline in Dementia?
- MoCA Versus MMSE: Which Test Is Better for Dementia Screening?
For more, see National Institute on Aging.
